Skip to main content
TipRanks
Go Ultimate75% OFF

Silence Therapeutics (XRP2) Income Statement

37 Followers

Silence Therapeutics Income Statement

Last quarter (Q3 2026), Silence Therapeutics's total revenue was £0.00, a decrease of 100.00% from the same quarter last year. In Q3, Silence Therapeutics's net income was £-12.43M. See Silence Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
£ 559.00K£ 43.26M£ 25.38M£ 17.65M£ 12.41M
£ 344.00K£ 31.45M£ 15.06M£ 6.68M£ 4.96M
£ 90.10M£ 94.77M£ 64.66M£ 56.44M£ 50.77M
Depreciation and Amortization£ 555.00K£ 463.32K£ 498.00K£ 490.91K£ 425.14K
£ -88.05M£ -49.12M£ -49.78M£ -39.93M―
£ -89.75M£ -63.32M£ -49.60M£ -49.76M£ -45.81M
£ 1.15M£ 18.86M£ -706.00K£ 9.29M£ -42.00K
£ -88.60M£ -44.46M£ -50.31M£ -40.47M£ -45.86M
£ -88.61M£ -45.31M£ -43.27M£ -41.03M£ -39.41M
Per Share Metrics
Basic EPS£ -5.67£ -2.37£ -3.48£ -3.78£ -1.35
Diluted EPS£ -5.67£ -2.37£ -3.48£ -3.78£ -1.35
Weighted Average Shares Outstanding15.74M15.42M12.36M10.73M29.65M
Weighted Average Shares Outstanding (Diluted)15.74M15.42M12.36M10.73M29.65M

Currency in GBP

Silence Therapeutics Earnings and Revenue History

-100M-50M050M-18000 %-12000 %-6000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin